Apogee Therapeutics Inc.
APGE
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.59B
Close$
$2.02
98.5% downside
Current Fair Value
98.5% downsideOvervalued by 98.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.59 Billion |
|---|---|
| Enterprise Value | $5.15 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.22 |
| Beta | 0.62 |
| Outstanding Shares | 69,668,439 |
Return
| Return on Equity | -16.60% |
|---|---|
| Return on Assets | -16.12% |
| Return on Invested Capital | -23.71% |
Valuation & Multiples
| P/E Ratio | -20.87 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | 7.38 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -17.23 |
| Enterprise Value to Net Income | -25 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 18, 2026
EPS Estimate
$-1.09
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 10, 2026
EPS Estimate
$-1.10
Average shareholder expectationRevenue Estimate
$10.00 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.4066▼ 2.52% |
|---|---|
| Total Calls | 884,166▲ 168.50% |
| Total Puts | 359,500▲ 152.81% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 130.27%▲ 11.56% |
|---|---|
| Total Invested | $6.64B▲ 26.06% |
| Investors Holding | 240▲ 25.00% |
ESG Score
No data